Posted byOrthoEx Posted in
Posted on Aug 08, 2018

RAYNHAM, Mass.Aug. 8, 2018 /PRNewswire/ — OMNIlife science, Inc. (“OMNI”), a privately-held, established medical technology company targeting the $15 billion global hip and knee replacement device market, announced today that Brigham Redd, M.D., of Liljenquist & Redd Orthopedic Surgery, is the first surgeon in Idaho to offer OMNIBotics, an advanced robotic-assisted treatment option for total knee replacement. This innovative total knee replacement solution is designed to relieve the pain caused by joint degeneration due to osteoarthritis. OMNIBotics is the global leader in robotic-assisted total knee replacement, with over 7 years of clinical use worldwide. This treatment option will be available for Dr. Redd’s patients at both Mountain View Hospital and Eastern Idaho Regional Medical Center in Idaho Falls, ID.

The OMNIBotics procedure utilizes advanced software and instrumentation to tailor each procedure to the patient’s unique anatomy in order to optimize implant fit and alignment. Patented OMNIBotics Bone Morphing™ technology eliminates the need for costly CT scans or MRIs and allows the surgeon to perform “virtual surgery” on a digital model before any bone is cut. A robotic cutting guide is then used by the surgeon when making the planned bone resections to ensure accuracy. The surgeon maintains control and decision-making regarding the total knee replacement while providing a customized, patient-specific surgery. OMNIBotics also allows for a less invasive surgical technique, compared to traditional knee replacement surgery, which may promote a quicker recovery.

“It’s been great to be able to check the accuracy of the surgery and make adjustments to perfect the angles and alignment of each step of surgery. This is so much more personalized and accurate than the traditional knee replacements done elsewhere,” said Dr. Redd. “It’s exciting to offer the most advanced technology to my patients and see them come back feeling even better than they do after a traditional knee replacement, and to be confident that their knee replacement will last even longer because of the precise and individualized alignment.”

ABOUT OMNIlife science™, Inc. (OMNI™)

OMNI is a privately held company with a proprietary robotic platform, OMNIBotics®, which allows surgeons to conduct patient-specific total knee surgery designed to enhance patient satisfaction and reduce hospital costs. In addition, OMNI designs, engineers, manufactures and distributes a wide range of proprietary hip and knee implants and is focused on providing cutting edge technologies to transform outcomes in joint replacement surgery and enhance a surgeon’s ability to help patients live active and pain-free lives. For more information about OMNI, please visit


Cindy Holloway, Director of Marketing Communications 

Phone: (508) 824-2444

SOURCE OMNIlife science, Inc.

Related Links